NAMD sent a letter to the Health Resources and Services Administration (HRSA) and the Centers for Medicare and Medicaid Services (CMS) to share our recent white paper discussing operational challenges in Medicaid’s interaction with the 340B drug discount program. The white paper is available here. Read the full letter here.

Continue reading

This NAMD working paper describes the challenges confronted by Medicaid programs in their interactions with the 340B drug discount program, including inconsistent guidance from federal agencies, the growth of contract pharmacy arrangements, and issues with Medicaid managed care programs. The paper also offers several recommendations to address the identified challenges. Read the full paper here.

Continue reading

On March 30th, NAMD released Perspectives on Innovation: A State Medicaid Approach to Evaluation. The paper describes the critical questions that state Medicaid programs ask themselves when evaluating the success of payment and delivery system reform – namely whether the reform is improving health outcomes relative to what preceded it, and whether there is a […]

Continue reading

The National Association of Medicaid Directors submitted a letter to the Centers for Medicare and Medicaid Services Acting Administrator Slavitt. The letter acknowledges progress made to improve Medicaid and Exchange interactions and calls for additional steps to improve the beneficiary experience and efficiency of operations. Read the full letter here.

Continue reading

NAMD submitted comments to the Substance Abuse and Mental Health Services Administration (SAMHSA) on the draft criteria for the state-certified community behavioral health clinic demonstration enacted under Sec. 223 of the Protecting Access to Medicare Act of 2014. The letter focuses on the need to finalize a CCBHC framework that is flexible enough to support […]

Continue reading